TESEVATINIB (KD019) VS PLACEBO FOR ADPKD: RESULTS OF A PH2B TRIAL

Rastogi, A; Fada, G; Rahbari-Oskoui, F; Park, M; Dahl, N; Perrone, R; Yang, ZM; Bhattacharya, S; Herrera, K; Eizenhamer, D; Kittner, B; Maski, M; Wang, L; Lin, J

AMERICAN JOURNAL OF KIDNEY DISEASES, 2023; 81 (4): S102